| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/19/2001 | US6248555 Nucleotide and amino acid sequence of mutant presenilin 1; diagnosis; screening; drug screening; probes; primers; host cells; vectors |
| 06/19/2001 | US6248554 DNA sequence coding for a BMP receptor |
| 06/19/2001 | US6248536 Bacillus thuringiensis CryET33 and CryET34 compositions and uses thereof |
| 06/19/2001 | US6248532 Detecting modulators of regulatory element; incubate nucleotide sequences with modulators, monitor binding to nucleotide sequences, comparing binding in the presence and absence modulators |
| 06/19/2001 | US6248523 Mammalian tumor susceptibility genes and their uses |
| 06/19/2001 | US6248521 Dew point in chamber is maintained to prevent evaporation of solution at discrete points of solid phase substrate where reactions are taking place |
| 06/19/2001 | US6248517 Amino acid sequences; diagnosis of lyme disease; recombinant production; vaccines |
| 06/19/2001 | US6248516 Library for expression of immunoglobulin heavy chain variable domains |
| 06/19/2001 | US6248513 In vitro detection of infection of cells by microorganism; incubate immunoglobulins with cells and detect the formation of protein immunoglobulin complexes |
| 06/19/2001 | US6248334 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
| 06/19/2001 | US6248333 Nucleic acids |
| 06/19/2001 | US6248332 Targeted immunostimulation with bispecific reagents |
| 06/19/2001 | US6248327 Using antibody |
| 06/19/2001 | CA2022539C Albumin derivatives with therapeutic functions |
| 06/19/2001 | CA2003307C Streptolysin o antigen derivative, its production and uses |
| 06/19/2001 | CA1341255C Therapeutic compositions against sterptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
| 06/14/2001 | WO2001042484A1 Il-6 like polynucleotide |
| 06/14/2001 | WO2001042472A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 06/14/2001 | WO2001042471A2 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | WO2001042465A2 Chordin-like molecules and uses thereof |
| 06/14/2001 | WO2001042460A1 Polynucleotides, polypeptides, remedies for cancer and vaccines |
| 06/14/2001 | WO2001042452A1 Novel promoter sequences and utilization thereof |
| 06/14/2001 | WO2001042451A2 FULL-LENGTH HUMAN cDNAs ENCODING POTENTIALLY SECRETED PROTEINS |
| 06/14/2001 | WO2001042437A2 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 06/14/2001 | WO2001042423A2 Compositions and methods for detecting stress-inducible proteins |
| 06/14/2001 | WO2001042420A1 Production of peptides by fedbatch cultivation of a microorganism |
| 06/14/2001 | WO2001042306A2 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042302A1 HUMAN PROTEIN AND cDNA |
| 06/14/2001 | WO2001042299A2 Hepatitis virus sentinel virus i (svi) |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042285A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 06/14/2001 | WO2001041792A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001009189A3 Compositions and methods for the treatment of tumors |
| 06/14/2001 | WO2001000829A8 Human endogenous retrovirus in breast cancer |
| 06/14/2001 | WO2000068413A8 Halo- or hydroxy-substituted nocathiacin antibiotics |
| 06/14/2001 | WO2000035950A9 Reagents and methods useful for detecting diseases of the breast |
| 06/14/2001 | US20010003848 For the preparation of transgenic crop plants, such as tobacco, potatoes, beets and maize with increased yield, by altering their nitrogen metabolism |
| 06/14/2001 | US20010003777 Individualized anti-cancer antibodies |
| 06/14/2001 | CA2394917A1 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | CA2393763A1 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 06/14/2001 | CA2393725A1 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393644A1 Hepatitis virus sentinel virus i (svi) |
| 06/14/2001 | CA2393589A1 Compositions and methods for detecting stress-inducible proteins |
| 06/14/2001 | CA2393532A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2392740A1 Il-6 like polynucleotides, polypeptides, and antibodies |
| 06/14/2001 | CA2392268A1 Production of peptides by fedbatch cultivation of a microorganism |
| 06/14/2001 | CA2390093A1 Extracellular matrix and cell adhesion molecules |
| 06/14/2001 | CA2382165A1 Full-length human cdnas encoding potentially secreted proteins |
| 06/13/2001 | EP1106701A1 Monoclonal antibody against canine trypsin |
| 06/13/2001 | EP1106696A1 Protein-deamidating enzyme, microorganism producing the same, gene encoding the same, production process therefor, and use thereof |
| 06/13/2001 | EP1106689A2 Nucleic acids encoding acetylcholine beta subunits from insects |
| 06/13/2001 | EP1106183A2 Antibodies to erbB2 and their therapeutic uses |
| 06/13/2001 | EP1105538A2 HUMAN STEAROYL-CoA DESATURASE-RELATED COMPOSITIONS AND METHODS FOR TREATING SKIN DISORDERS |
| 06/13/2001 | EP1105508A1 Method for purifying proteins and biomolecule or protein complexes |
| 06/13/2001 | EP1105507A1 Overexpression of desired proteins in eukaryotic cells mediated by cyclin d1 overexpression |
| 06/13/2001 | EP1105503A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1) |
| 06/13/2001 | EP1105488A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 06/13/2001 | EP1105487A1 Recombinant multivalent malarial vaccine against plasmodium falciparum |
| 06/13/2001 | EP1105485A1 Human il-1 epsilon dna and polypeptides |
| 06/13/2001 | EP1105483A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 06/13/2001 | EP1105481A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 06/13/2001 | EP1105480A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family |
| 06/13/2001 | EP1105479A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 06/13/2001 | EP1105478A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 06/13/2001 | EP1105477A1 Dcr5, a bmp-binding protein, and applications thereof |
| 06/13/2001 | EP1105475A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia |
| 06/13/2001 | EP1105473A2 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof |
| 06/13/2001 | EP1105472A2 Domain specific gene evolution |
| 06/13/2001 | EP1105466A1 Process for purifying human papillomavirus virus-like particles |
| 06/13/2001 | EP1105465A1 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE |
| 06/13/2001 | EP1105427A2 Generation of modified molecules with increased serum half-lives |
| 06/13/2001 | EP1105425A1 Monoclonal antibodies specific for streptococcus mutans, and uses thereof |
| 06/13/2001 | EP1105421A2 Anti-inflammatory peptides derived from il-2 and analogues thereof |
| 06/13/2001 | EP1105418A1 Vanadate resistance glycosylation 4 gene |
| 06/13/2001 | EP1105414A2 Synthetic peptides and methods of use for autoimmune disease therapies |
| 06/13/2001 | EP1105413A2 Hepatitis c inhibitor tri-peptides |
| 06/13/2001 | EP1105411A1 nrdE |
| 06/13/2001 | EP1105406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 06/13/2001 | EP1105360A1 Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
| 06/13/2001 | EP1105158A1 Synthetic peptide immunogens and antibodies thereto |
| 06/13/2001 | EP1105154A1 Bacterial superantigen vaccines |
| 06/13/2001 | EP1105153A1 Multivalent vaccine for (clostridium botulinum) neurotoxin |
| 06/13/2001 | EP1105143A1 Human histone deacetylase gene hd4 |
| 06/13/2001 | EP1105051A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
| 06/13/2001 | EP1104993A1 C3a serum-free clonal cell line and methods of use |
| 06/13/2001 | EP0789776B1 Nucleic acid transfer system |
| 06/13/2001 | EP0725798B1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridoma |
| 06/13/2001 | EP0580649B1 Plant promoter involved in controlling lipid biosynthesis in seeds |
| 06/13/2001 | DE19963690A1 Vektoren und Verfahren zur Herstellung rekombinanter Proteine in Pilzen Vectors and methods for producing recombinant proteins in fungi |
| 06/13/2001 | DE19959582A1 Nukleinsäuren, die für neue Acetylcholinrezeptor-beta-Untereinheiten von Insekten kodieren Nucleic acids coding for new acetylcholine receptor beta subunits of insect |
| 06/13/2001 | CN1299414A Compound and method for therapy and diagnosis of lung cancer |
| 06/13/2001 | CN1299411A Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
| 06/13/2001 | CN1299410A CD 19XCD2 specific polypeptides and uses thereof |
| 06/13/2001 | CN1299272A Method and device for modulating the immune response |
| 06/13/2001 | CN1298949A Process for preparing human seralbumin from pichia pastoris |
| 06/13/2001 | CN1298882A Human Na-dependent phosphate cotransporter 35 and its coding sequence |
| 06/13/2001 | CN1067104C Method for prepn. of secretion of hirudin derivatives |